StockWatch
·
Biotechnology: Pharmaceutical Preparations
Corporate ActionJul 15, 2026, 04:02 PM

Erasca Closes $632.5M Upsized Public Offering

AI Summary

Erasca, Inc. announced the successful closing of its previously announced upsized public offering, raising approximately $632.5 million in gross proceeds. The company sold 36,142,857 shares of its common stock at a price of $17.50 per share, which included the full exercise of the underwriters' option to purchase additional shares. Erasca plans to utilize the net proceeds from this offering, combined with its existing cash, to fund the research and development of its product candidates and for general corporate purposes.

Key Highlights

  • Closed an upsized public offering of common stock.
  • Generated approximately $632.5 million in gross proceeds from the offering.
  • Sold a total of 36,142,857 shares of common stock.
  • Shares were sold to the public at a price of $17.50 per share.
  • Included 4,714,285 shares from the underwriters' full option exercise.
  • Net proceeds will fund research and development of product candidates.
  • Proceeds also allocated for working capital and general corporate purposes.
  • J.P. Morgan, Morgan Stanley, Jefferies, and Evercore ISI were joint book-running managers.